This is because of too little safety data and case reports that cant exclude harm
Peptide therapy can cover a range of options for energy, recovery, and metabolic health, depending on the clinical situation
A well-designed network meta-analysis (NMA) of GLP-1 receptor agonists and SGLT2 inhibitors, which allows for direct comparisons among different medications, could enhance the ability to make multiple treatment efficacy comparisons and assess the potential superiority of specific interventions at various dosages [12]
"I had a great experience and Im honestly very happy with my results
Side effects for GLP-1s may include nausea, vomiting, stomach pain, upset stomach, dizziness, constipation, feeling bloated, belching, gas, headaches and fatigue